Fig. 2From: The efficacy and safety of induction chemotherapy combined with concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in nasopharyngeal carcinoma patients: a systematic review and meta-analysisForest plots of hazard ratios for 3-year (a) and 5-year (b) overall survival in nasopharyngeal carcinomaBack to article page